ATS gets EU OK for latest Open Pivot heart valve:
This article was originally published in Clinica
ATS Medical has received European market approval for an improved version of its open pivot mechanical heart valve. The company said it has maximised the haemodynamic performance of the new device, called Open Pivot AP360, and has incorporated a cuff design that it believes will extend its appeal to a broader spectrum of surgeons. The flexible, flanged polyester cuff provides improved suturability, flexibility and conformability, explained the Minneapolis, Minnesota firm. As with the earlier open pivot design, the new valve has no recesses or cavities that can promote thrombus formation, and incorporates a strengthening band of the cobalt-chrome alloy MP35N, providing for compressive strength and durability.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.